Intuitive Surgical, Inc. (ISRG) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ISRG Revenue Growth
Revenue Breakdown (FY 2025)
ISRG's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
ISRG Revenue Analysis (2014–2025)
As of May 8, 2026, Intuitive Surgical, Inc. (ISRG) generated trailing twelve-month (TTM) revenue of $10.58 billion, reflecting exceptional growth of +23.0% year-over-year. The most recent quarter (Q1 2026) recorded $2.77 billion in revenue, down 3.3% sequentially.
Looking at the longer-term picture, ISRG's 5-year compound annual growth rate (CAGR) stands at +18.2%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $10.06 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows ISRG's business is primarily driven by Instruments and Accessories (60%), Systems (25%), and Services (16%). With over half of revenue concentrated in Instruments and Accessories, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including SYK (+11.2% YoY), MDT (+6.9% YoY), and BSX (+19.9% YoY), ISRG has outperformed the peer group in terms of revenue growth. Compare ISRG vs SYK →
ISRG Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ISRGCurrent | $10.6B | +23.0% | +18.2% | 29.3% | |
 SYK | $25.1B | +11.2% | +11.8% | 19.5% | |
 MDT | $33.5B | +6.9% | +3.0% | 17.8% | |
 BSX | $20.1B | +19.9% | +15.2% | 19.8% | |
 ZBH | $8.2B | +9.2% | +6.1% | 16.5% | |
 HOLX | $4.1B | +2.2% | +1.7% | 17.4% |
ISRG Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $10.06B | +20.5% | $6.64B | 66.0% | $2.95B | 29.3% |
| 2024 | $8.35B | +17.2% | $5.63B | 67.5% | $2.35B | 28.1% |
| 2023 | $7.12B | +14.5% | $4.73B | 66.4% | $1.77B | 24.8% |
| 2022 | $6.22B | +9.0% | $4.20B | 67.4% | $1.58B | 25.3% |
| 2021 | $5.71B | +31.0% | $3.96B | 69.3% | $1.82B | 31.9% |
| 2020 | $4.36B | -2.7% | $2.86B | 65.6% | $1.05B | 24.1% |
| 2019 | $4.48B | +20.3% | $3.11B | 69.4% | $1.37B | 30.7% |
| 2018 | $3.72B | +19.0% | $2.60B | 69.9% | $1.20B | 32.2% |
| 2017 | $3.13B | +15.7% | $2.19B | 70.1% | $1.05B | 33.7% |
| 2016 | $2.70B | +13.4% | $1.89B | 69.9% | $945.2M | 35.0% |
Full ISRG Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Should I Buy ISRG Right Now?
Bull case, key risks, Wall St analyst verdict, and what council investors are saying — updated daily.
See ISRG's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ISRG Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ISRG vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonISRG — Frequently Asked Questions
Quick answers to the most common questions about buying ISRG stock.
Is ISRG's revenue growth accelerating or slowing?
ISRG revenue is accelerating at +23.0% year-over-year, exceeding the 5-year CAGR of +18.2%. TTM revenue reached $10.6B. Growth momentum has increased versus prior periods.
What is ISRG's long-term revenue growth rate?
Intuitive Surgical, Inc.'s 5-year revenue CAGR of +18.2% reflects the sustained expansion pattern. Current YoY growth of +23.0% is above this long-term average.
How is ISRG's revenue distributed by segment?
ISRG reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.